A complex surgical trial for a novel imaging agent was stalled by overly restrictive patient criteria. The stringent eligibility threatened to derail the entire Phase II-III program. Through close collaboration with sites, we implemented a critical protocol amendment to broaden patient access. This strategic shift rapidly accelerated recruitment, turning a major obstacle into a success. Discover the agile problem-solving that kept this challenging study on track.
Download the full case study to learn how we navigate complex clinical challenges.
